Hoitt Jason
- SEC CIK
- 0001762572
In the past year, 1 open-market sale filing worth $119.3K and no purchases.
Current role at each company
- STOK Stoke Therapeutics, Inc.Chief Patient Officeras of Mar 19, 2026
- PRVB Provention Bio, Inc.Chief Commercial Officeras of Apr 27, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $119.3K
- 1 filing
- Net
- −$119.3K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Hoitt Jason as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
STOK Stoke Therapeutics, Inc.
Chief Patient Officer1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 19, 2026 (view filing) | Mar 17-18 | 2 days | Hoitt JasonChief Patient Officer | SSale | −3.71K | $32.14 | −$119.3K | −26.5%10.3K after | 5 lots |
PRVB Provention Bio, Inc.
Chief Commercial Officer1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 14, 2023 (view filing) | Feb 10 | 4 days | Hoitt JasonChief Commercial Officer | SSale | −4.50K | $10.00 | −$45.0K | −100.0%0 after |